The Office of National Drug Control Policy (ONDCP) today hosted a Washington, D.C., symposium intended to accelerate the medical community's involvement in substance use prevention and treatment. Leaders of several federal agencies met with representatives of numerous primary care and speciality medical boards, with the latter group including the American Board of Addiction Medicine (ABAM) Foundation.
Federal leaders that included ONDCP director Michael Botticelli highlighted the need to integrate addiction medicine competencies (covering prevention, treatment and recovery) into graduate medical training, certification and practice. “America must bring the power of medicine and public health to bear to reduce substance use and its consequences,” said Botticelli.
Three current and 17 prospective addiction medicine fellowship training programs were represented at the symposium. The ABAM Foundation has established fellowship programs at 36 medical schools and teaching hospitals, and would like to see 125 accredited fellowship programs in the country by 2025. “It is our hope that today's meering will result in a lasting structure for public-private collaboration in order to further develop the physician workforce to address our nation's number one public health problem,” said ABAM Foundation president Patrick G. O'Connor, MD, MPH.
The American Board of Preventive Medicine has begun a process under which addiction medicine would be a subspecialty available to professionals from all fields of medicine.